These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24006594)

  • 1. [Management of benign prostate syndrome].
    Herlemann A; Strittmatter F; Stief CG; Gratzke C
    MMW Fortschr Med; 2013 Aug; 155(14):39-42. PubMed ID: 24006594
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower urinary tract symptoms in men.
    Hollingsworth JM; Wilt TJ
    BMJ; 2014 Aug; 349():g4474. PubMed ID: 25125424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Benign Prostatic Hyperplasia in Older Adults.
    Woodard TJ; Manigault KR; McBurrows NN; Wray TL; Woodard LM
    Consult Pharm; 2016; 31(8):412-24. PubMed ID: 27535076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the multiple symptoms of benign prostatic hyperplasia.
    Miner M
    J Fam Pract; 2012 Jun; 61(6 Suppl):S5-10. PubMed ID: 22670247
    [No Abstract]   [Full Text] [Related]  

  • 5. Benign prostatic hyperplasia in 2014: Innovations in medical and surgical treatment.
    De Nunzio C; Tubaro A
    Nat Rev Urol; 2015 Feb; 12(2):76-8. PubMed ID: 25558836
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy for non-neurogenic male lower urinary tract symptoms: 1 + 1 does not equal 2.
    Lepor H
    Eur Urol; 2013 Aug; 64(2):244-6; discussion 246-7. PubMed ID: 23473577
    [No Abstract]   [Full Text] [Related]  

  • 7. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BPH update: medical versus interventional management.
    Blankstein U; Van Asseldonk B; Elterman DS
    Can J Urol; 2016 Feb; 23(Suppl 1):10-5. PubMed ID: 26924590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
    Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
    Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urination disorders in the man: differential diagnoses and therapy of benign prostate syndrome].
    Meyer D; Schmid HP
    Praxis (Bern 1994); 2013 Oct; 102(20):1237-42. PubMed ID: 24088234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Medical Therapy and Success of Laser Surgery and Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
    Strope SA; Vetter J; Elliott S; Andriole GL; Olsen MA
    Urology; 2015 Dec; 86(6):1115-22. PubMed ID: 26375848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of benign prostatic hyperplasia.
    Nunes RV; Manzano J; Truzzi JC; Nardi A; Silvinato A; Bernardo WM;
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):95-99. PubMed ID: 28355368
    [No Abstract]   [Full Text] [Related]  

  • 13. [Up-to-date on the treatment of benign prostatic hyperplasia. Which adenoma to treat and how to do it?].
    Lahlaidi K; Ariane MM; Fontaine E
    Rev Med Interne; 2014 Mar; 35(3):189-95. PubMed ID: 24262410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Benign Prostatic Hyperplasia.
    Kim EH; Larson JA; Andriole GL
    Annu Rev Med; 2016; 67():137-51. PubMed ID: 26331999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of combination drug therapy for non-neurogenic male lower urinary tract symptoms.
    Füllhase C; Chapple C; Cornu JN; De Nunzio C; Gratzke C; Kaplan SA; Marberger M; Montorsi F; Novara G; Oelke M; Porst H; Roehrborn C; Stief C; McVary KT
    Eur Urol; 2013 Aug; 64(2):228-43. PubMed ID: 23375241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice. Benign prostatic hyperplasia and lower urinary tract symptoms.
    Sarma AV; Wei JT
    N Engl J Med; 2012 Jul; 367(3):248-57. PubMed ID: 22808960
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of benign prostatic hyperplasia.
    Pinheiro LC; Martins Pisco J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):256-60. PubMed ID: 23244720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign prostatic hyperplasia and prostate cancer: an overview for primary care physicians.
    Sausville J; Naslund M
    Int J Clin Pract; 2010 Dec; 64(13):1740-5. PubMed ID: 21070524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailoring treatment in benign prostatic hyperplasia management.
    de la Rosette JJ
    Curr Opin Urol; 2009 Jan; 19(1):1-2. PubMed ID: 19057208
    [No Abstract]   [Full Text] [Related]  

  • 20. [Update on current care guidelines: benign prostatic hyperplasia].
    Tammela T; Nurmi M; Pétas A; Sipilä R; Taari K
    Duodecim; 2012; 128(10):1046-7. PubMed ID: 22724320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.